American Regent Recalls Specific Lots of Concentrated Sodium Chloride Injection Due to Particulates

The following recall is being posted as some veterinarians may use this product in treating their patients.

Customer Service: (877) 788-3232

This recall was initiated because some of the vials of these lots may contain visible particulates. Potential adverse events after intravenous administration of solutions containing particulates may include disruption of blood flow within small blood vessels in the lung, localized inflammation (swelling and redness due to accumulation of inflammatory cells), and granuloma formation. American Regent is undertaking this voluntary recall in consideration of the potential for safety issues if these lots of product are administered to patients.

Concentrated Sodium Chloride Injection, USP, 23.4% is indicated as an additive in parenteral fluid therapy for use in patients who have special problems of sodium electrolyte intake or excretion. It is intended to meet the specific requirement of the patient with unusual fluid and electrolyte needs.

The product was distributed to wholesalers and distributors nationwide.

Hospitals, infusion centers, clinics and other healthcare facilities should not use American Regent Inc., Concentrated Sodium Chloride Injection, USP, 23.4% with the lot #s on the attached Appendix for patient care and should immediately quarantine any product for return.

American Regent has identified the source of the particulates and has taken the necessary steps to correct this issue. The company is initiating this voluntary recall for these lots manufactured prior to the implementation of this corrective action. American Regent has informed the FDA of its actions and is maintaining ongoing discussions with the agency.

As is standard practice, and as stated in the Concentrated Sodium Chloride Injection, USP Product Package Insert, “Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.”

American Regent will credit accounts for all returned product with these lot #s. Those with questions about the return or recall process, please call our Customer Service Department at 1-877-788-3232: Monday thru Friday from 8:30AM to 7:00PM ET.

Hospitals, emergency rooms, infusion centers, clinics and healthcare providers, or patients with product quality complaints, medical or other questions concerning the use of the product or reasons for this recall should contact the Professional Services Department at 1-877-788-3232.

Any adverse reactions experienced with the use of this product should be reported to American Regent, Inc. via email at PV@luitpold.com, by fax to (610) 650-7781 or (610) 650-0170 or by phone at 1-800-734-9236.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program online, or regular mail or by fax.

 

APPENDIX

Recalled Lots of Concentrated Sodium Chloride Injection, USP, 23.4%

Concentrated Sodium Chloride Injection, USP, 23.4%, 30 mL Single Dose Vial NDC # 0517-2930-25

Lot#Expiration DateFirst Distribution Date
919803/31/201104/21/2009
925204/30/201105/21/2009
929904/30/201106/01/2009
930505/31/201106/23/2009
940206/30/201107/13/2009
942306/30/201107/30/2009
943206/30/201108/20/2009
955308/31/201109/11/2009
959508/31/201110/05/2009
964609/30/201110/28/2009
968110/31/201111/23/2009
973710/31/201112/21/2009
979711/30/201101/11/2010
983112/31/201102/08/2010
005101/31/201203/02/2010
009502/28/201203/17/2010

Concentrated Sodium Chloride Injection, USP, 23.4%, 100 mL Pharmacy Bulk Package NDC # 0517-2900-25

Lot #Expiration DateFirst Distribution Date
922504/30/201105/06/2009
949207/31/201108/07/2009
971110/31/201111/03/2009
000701/31/201201/26/2010
005801/31/201203/02/2010

 

Published: March 16, 2011;    Updated: March 17, 2011

Filed Under: Recalls Warnings

Source: FDA

)